Study #2017-0661
A Pilot Study of NKTR-214 and Nivolumab in Selected Patients with Locally Advanced/Metastatic Sarcoma (CA209-9EM)
MD Anderson Study Status
Not Accepting
Treatment Agent
NKTR-214, Nivolumab
Description
The purpose of this study is to test any good and bad effects of the combination of study drugs called NKTR-214 and nivolumab.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
SARCOMA
Study phase:
Phase II
Physician name:
Anthony Conley
Department:
Sarcoma Medical Oncology
For general questions about clinical trials:
1-844-317-6206
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.